Lebanese Interhospital Pneumococcal Surveillance Program
NCT00901602 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2023-02-03
Summary
Streptococcus pneumoniae (pneumococcus) is a bacterium that causes severe infections in children and adults such as meningitis, pneumonia, and blood stream infection. There are many types of these bacteria defined by the type of sugar coat that they have. These are classified as serotypes. There are common serotypes that cause severe disease and are preventable by vaccination of children. Other less common types are more difficult to prevent. The investigators aim to determine the serotypes that cause invasive pneumococcal disease in Lebanon and to study their sensitivity to different antibiotics. The investigators will collect bacterial isolates from different hospitals in Lebanon isolated from the blood or spinal fluid of patients with invasive pneumococcal disease. This information will help the investigators determine the usefulness of available pneumococcal vaccines in preventing these infections. The data will be distributed to all primary care physicians treating children in Lebanon and will be shared with the Ministry of Health.
Conditions
- Pneumonia
- Meningitis
- Sepsis
- Bacteremia
Sponsors & Collaborators
-
PneumoADIP
collaborator UNKNOWN - collaborator INDUSTRY
-
American University of Beirut Medical Center
lead OTHER
Principal Investigators
-
Ghassan S Dbaibo, M.D. · American University of Beirut Medical Center
Eligibility
- Min Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Primary Completion
- 2030-10-31
- Completion
- 2030-10-31
Countries
- Lebanon
Study Locations
More Related Trials
-
Impact of the 7 Valent Pneumococcal Conjugate Vaccine (7vPCV) on Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Jordanian Infants
NCT00900978 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants
NCT02308540 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults
NCT03549208 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years
NCT02955160 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease
NCT00918580 ·Status: COMPLETED ·Phase: PHASE3
-
Colombia Epidemiologic Surveillance Study
NCT00428051 ·Status: TERMINATED
-
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
NCT01619462 ·Status: UNKNOWN ·Phase: PHASE3
-
Study Evaluating Persistence Of Antibody Response Elicited By 13vPnC In Healthy Adults Previously Vaccinated
NCT01025336 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized Adults
NCT02052154 ·Status: COMPLETED ·Phase: PHASE2
-
PREVENTING PNEUMOcoccal Disease Through Vaccination (Study 2)
NCT04974294 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Assess the Carriage of Pneumococci in Children Aged 1-5 Years, and Their Household Contacts
NCT02522546 ·Status: COMPLETED
-
Child Pneumococcal Serotype Epidemiology In Greece
NCT01111214 ·Status: COMPLETED
-
Recombinant Attenuated Salmonella Typhi Vaccine Vectors Producing Streptococcus Pneumoniae PspA
NCT01033409 ·Status: COMPLETED ·Phase: PHASE1
-
Pneumonia Research and Vaccine Impact League
NCT03900520 ·Status: COMPLETED
-
Safety Study of a Single Dose of Pneumococcal Whole-Cell Vaccine in Healthy Adults
NCT07059182 ·Status: COMPLETED ·Phase: PHASE1
-
Experimental Human Pneumococcal Challenge With SPN3
NCT05535868 ·Status: UNKNOWN ·Phase: NA
-
Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)
NCT06698198 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage
NCT00294021 ·Status: COMPLETED
-
Effect of Two Versus Three Pneumococcal Conjugate Vaccinations
NCT00189020 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I to Test a New Pneumococcal Vaccine
NCT03303976 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation of PCV13 Vaccine Schedules, Comparing Impact of 2+1 vs 3+0 on Pneumococcal Carriage in Blantyre, Malawi
NCT04078997 ·Status: COMPLETED
-
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
NCT05114902 ·Status: UNKNOWN
-
Evaluation of Pneumococcal Vaccine Formulations in Elderly
NCT00756067 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
NCT06182124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Immunity to Serotype 19A Streptococcus Pneumoniae in Children Vaccinated With PCV10
NCT04912297 ·Status: COMPLETED